It was shown in preclinical models that administration of FGF21 or its mimetics and analogs reduces body weight, blood glucose levels, improves blood lipid profiles, increases insulin sensitivity [6,7,8], and protects from fatty liver disease [9,10] in obese animals. Here, INS is linked to fatty liver disease.